Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
Prudent Markets analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global Bioresorbable Scaffold market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Bioresorbable Scaffold Market by Prudent Markets Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Bioresorbable Scaffold Market
Abbott Laboratories (U.S.)
Biotronik (Germany)
REVA Medical, Inc. (U.S.)
Elixir Medical Corporation (U.S.)
Kyoto Medical Planning Co., Ltd. (Japan)
Amaranth Medical, Inc.
Arterial Remodeling Technologies
Meril Life Sciences Pvt. Ltd.
Arterius Limited
LEPU MEDICAL TECHNOLOGY CO., LTD.
Boston Scientific Corporation
480 Biomedical
S3V Vascular Technologies Private Limited
Qualimed (Part of Q3 Medical Group)
ORBUSNEICH
...
Major Type of Bioresorbable Scaffold Covered in Prudent Markets report:
Degradable Polymer Materials
Degradable Inorganic Materials
Composite Materials
Application Segments Covered in Prudent Markets Market
Hospitals
Cardiac Centers
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Bioresorbable Scaffold Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Degradable Polymer Materials -Product Introduction and Major Manufacturers
1.1.2 Degradable Inorganic Materials -Product Introduction and Major Manufacturers
1.1.3 Composite Materials -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Bioresorbable Scaffold Status and Prospect (2015-2026)
2.1.1 China Bioresorbable Scaffold Market Size and Growth Rate (2015-2026)
2.1.2 China Bioresorbable Scaffold Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Bioresorbable Scaffold Status and Prospect (2015-2026)
2.2.1 EU Bioresorbable Scaffold Market Size and Growth Rate (2015-2026)
2.2.2 EU Bioresorbable Scaffold Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Bioresorbable Scaffold Status and Prospect (2015-2026)
2.3.1 USA Bioresorbable Scaffold Market Size and Growth Rate (2015-2026)
2.3.2 USA Bioresorbable Scaffold Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Bioresorbable Scaffold Status and Prospect (2015-2026)
2.4.1 Japan Bioresorbable Scaffold Market Size and Growth Rate (2015-2026)
2.4.2 Japan Bioresorbable Scaffold Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Bioresorbable Scaffold Status and Prospect (2015-2026)
2.5.1 India Bioresorbable Scaffold Market Size and Growth Rate (2015-2026)
2.5.2 India Bioresorbable Scaffold Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Bioresorbable Scaffold Status and Prospect (2015-2026)
2.6.1 Southeast Asia Bioresorbable Scaffold Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Bioresorbable Scaffold Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Bioresorbable Scaffold Status and Prospect (2015-2026)
2.7.1 South America Bioresorbable Scaffold Market Size and Growth Rate (2015-2026)
2.7.2 South America Bioresorbable Scaffold Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Bioresorbable Scaffold Status and Prospect (2015-2026)
2.8.1 Bioresorbable Scaffold Market Size and Growth Rate (2015-2026)
2.8.2 Bioresorbable Scaffold Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Bioresorbable Scaffold Market Assessment by Segment
3.1 Global Bioresorbable Scaffold Capacity and Growth Rate
3.2 Global Bioresorbable Scaffold Sales by Type
3.3 Global Bioresorbable Scaffold Sales Revenue by Type
3.4 Global Bioresorbable Scaffold Consumption by Application
4 Global Bioresorbable Scaffold Market Assessment by Regions
4.1 Global Bioresorbable Scaffold Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Bioresorbable Scaffold Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Bioresorbable Scaffold Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Bioresorbable Scaffold Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Bioresorbable Scaffold Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Bioresorbable Scaffold Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Bioresorbable Scaffold Sales Market Share of Manufacturers (2019-2020)
6.3 Global Bioresorbable Scaffold Sales Revenue Market Share of Manufacturers (2019-2020)
7 Bioresorbable Scaffold Competitive Analysis
7.1 Abbott Laboratories (U.S.)
7.1.1 Abbott Laboratories (U.S.) Company Profiles
7.1.2 Abbott Laboratories (U.S.) Product Introduction
7.1.3 Abbott Laboratories (U.S.) Bioresorbable Scaffold Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Biotronik (Germany)
7.2.1 Biotronik (Germany) Company Profiles
7.2.2 Biotronik (Germany) Product Introduction
7.2.3 Biotronik (Germany) Bioresorbable Scaffold Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 REVA Medical, Inc. (U.S.)
7.3.1 REVA Medical, Inc. (U.S.) Company Profiles
7.3.2 REVA Medical, Inc. (U.S.) Product Introduction
7.3.3 REVA Medical, Inc. (U.S.) Bioresorbable Scaffold Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Elixir Medical Corporation (U.S.)
7.4.1 Elixir Medical Corporation (U.S.) Company Profiles
7.4.2 Elixir Medical Corporation (U.S.) Product Introduction
7.4.3 Elixir Medical Corporation (U.S.) Bioresorbable Scaffold Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Kyoto Medical Planning Co., Ltd. (Japan)
7.5.1 Kyoto Medical Planning Co., Ltd. (Japan) Company Profiles
7.5.2 Kyoto Medical Planning Co., Ltd. (Japan) Product Introduction
7.5.3 Kyoto Medical Planning Co., Ltd. (Japan) Bioresorbable Scaffold Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Amaranth Medical, Inc.
7.6.1 Amaranth Medical, Inc. Company Profiles
7.6.2 Amaranth Medical, Inc. Product Introduction
7.6.3 Amaranth Medical, Inc. Bioresorbable Scaffold Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Arterial Remodeling Technologies
7.7.1 Arterial Remodeling Technologies Company Profiles
7.7.2 Arterial Remodeling Technologies Product Introduction
7.7.3 Arterial Remodeling Technologies Bioresorbable Scaffold Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Meril Life Sciences Pvt. Ltd.
7.8.1 Meril Life Sciences Pvt. Ltd. Company Profiles
7.8.2 Meril Life Sciences Pvt. Ltd. Product Introduction
7.8.3 Meril Life Sciences Pvt. Ltd. Bioresorbable Scaffold Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Arterius Limited
7.9.1 Arterius Limited Company Profiles
7.9.2 Arterius Limited Product Introduction
7.9.3 Arterius Limited Bioresorbable Scaffold Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 LEPU MEDICAL TECHNOLOGY CO., LTD.
7.10.1 LEPU MEDICAL TECHNOLOGY CO., LTD. Company Profiles
7.10.2 LEPU MEDICAL TECHNOLOGY CO., LTD. Product Introduction
7.10.3 LEPU MEDICAL TECHNOLOGY CO., LTD. Bioresorbable Scaffold Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 Boston Scientific Corporation
7.12 480 Biomedical
7.13 S3V Vascular Technologies Private Limited
7.14 Qualimed (Part of Q3 Medical Group)
7.15 ORBUSNEICH
8 Conclusion